
Photo: CNBC
Business & Finance
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
TL;DR
- Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Nov 16, 2026 · Updated 11/16/2026, 3:09:07 PM · Reported with: CNBC
Sources (1)
NRI Bytes writes its own articles from the reporting below.
CNBC — Novo says Wegovy injection lowers BMI and obesity rates in children in trialUp next · Business & Finance
Dubious claims on labels may get product barred
Read next →
More stories

Business & Finance
GIFT City eyes global commodity trade; finance, liquidity could pose hurdles
40m ago

Business & Finance
How telecom stocks went from dividend darlings to portfolio poison
40m ago
Business & Finance
Nvidia earnings report beats expectations, raising predictions for next year
40m ago
Business & Finance
'Srinivasan, Singh selectively picking facts': Ex-Tata Trusts trustee Khambata
40m ago